Trial Profile
An open-label study of photodynamic therapy with ME2906 and PNL6405CNS in patients with malignant brain tumor
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Talaporfin (Primary)
- Indications Brain metastases
- Focus Therapeutic Use
- 06 Jun 2016 New trial record